Global Elastomeric Infusion Pumps Market

Elastomeric Infusion Pumps Market Size, Share, Growth Analysis, By Type(Continuous Rate Elastomeric Pump and Variable Rate Elastomeric Infusion Pump), By Application(Pain Management, Chemotherapy), By End-user(Hospitals, Ambulatory Surgical Centers) - Industry Forecast 2024-2031

Report ID: SQMIG35A2679 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 89 | Figures: 76

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Elastomeric Infusion Pumps Market size was valued at USD 977.84 million in 2021 and is poised to grow from USD 1067.8 million in 2022 to USD 2159.09 million by 2030, at a CAGR of 9.2 % during the forecast period (2023-2030).

The elastomeric infusion systems market exhibits a moderate level of fragmentation and competitiveness. Market players are actively engaged in strategies such as new product launches, collaborations, and innovations to strengthen their market presence and increase their share. These industry participants continually strive to introduce advanced solutions, forge strategic partnerships, and drive innovation, positioning themselves to capture a larger market share in the dynamic elastomeric infusion systems market. 'Baxter International Inc. (US)', 'B. Braun Melsungen AG (Germany)', 'Avanos Medical, Inc. (US)', 'Nipro Corporation (Japan)', 'Leventon S.A.U (Spain)', 'Fresenius Kabi AG (Germany)', 'Terumo Corporation (Japan)', 'Smiths Medical (UK)', 'CME Medical (United Kingdom)', 'Vygon Group (France)', 'Q Core Medical Ltd. (Israel)', 'Woo Young Medical Co., Ltd. (South Korea)', 'Romsons Group of Industries (India)', 'Halyard Health, Inc. (US)', 'Sooil Development Co., Ltd. (South Korea)', 'Micrel Medical Devices SA (Switzerland)', 'Coopdech (China)', 'Polymedicure Ltd. (India)', 'Shanghai Kindly Medical Instruments Co., Ltd. (China)', 'Coloplast Group (Denmark)'

The rising incidence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is a significant driver for the elastomeric infusion pumps market. These pumps provide a reliable and convenient method of delivering medications for long-term management of chronic conditions.

There was a growing trend towards home healthcare and ambulatory care, driven by factors such as the rising elderly population, preference for cost-effective treatment options, and advancements in medical technology. Elastomeric infusion pumps were being increasingly utilized in homecare settings due to their ease of use, portability, and ability to provide continuous infusion of medications without the need for electronic programming. This trend allowed patients to receive treatment outside of traditional healthcare facilities, promoting patient comfort and reducing the burden on healthcare facilities.

In the elastomeric infusion pumps market, regional insights reveal a dynamic landscape driven by various factors across different regions. North America emerges as the largest market segment, primarily due to the region's advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on technological advancements. The increasing prevalence of chronic diseases, rising demand for pain management solutions, and extensive adoption of elastomeric infusion pumps contribute to the dominance of North America in the market.

Related Reports

Middle East Medical Device Market
Buy Now GET FREE SAMPLE
Medical Image Management Market
Buy Now GET FREE SAMPLE
Pneumatic Nebulizers Market
Buy Now GET FREE SAMPLE
Blood Pressure Monitors Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Elastomeric Infusion Pumps Market

Product ID: SQMIG35A2679

$5,300
BUY NOW GET FREE SAMPLE